Weekly Policy Blog: Campaign & Legislation Support Colorado’s Drive to Be a Leading Life Sciences Hub 

Colorado BioScience Association and a consortium of 22 Colorado partners have launched Colorado Hub for Health Impact, a new national economic development campaign to position Colorado as America’s ep...

Learn More

Weekly Policy Blog: CBSA’s 2024 Day at the Capitol 

CBSA held its annual Day at the Capitol event on February 28. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which highlighted...

Learn More

Weekly Policy Blog: PDAB Initiates Upper Payment Limit Rulemaking Process for the First Time 

On Friday, February 23, the Colorado Prescription Drug Affordability Board (PDAB or Board) decided to initiate an “upper payment limit” (UPL) rulemaking process for the autoimmune disease drug Enbrel...

Learn More

Weekly Policy Blog: Legislative Session Update 

The first few weeks of the Colorado legislative session require intensive engagement at the Capitol and comprehensive review of proposed legislation by CBSA's Policy + Advocacy team to support a colla...

Learn More

Weekly Policy Blog: Take Action to Protect America’s Innovation Economy 

CBSA urges you to take action now to protect America’s innovation economy! The federal government is considering the use of “march-in rights” (where it could compel a patent-owner to license an invent...

Learn More

Weekly Policy Blog: Urge Congress to Fix R&D Expensing 

CBSA and our partners at BIO urge you to act now! Encourage members of Congress to pass a tax package before the end of January that includes restoration of immediate R&D expensing to protect our...

Learn More

Weekly Policy Blog: Start of the 2024 Colorado Legislative Session 

Colorado’s 2024 legislative session kicked off on Wednesday, January 10th, and will continue for 120 days until May 8th.   The Legislature: For the sixth year, Democrats have total control o...

Learn More

Weekly Policy Blog: CBSA Releases 2023 Policy + Advocacy Report 

Colorado BioScience Association (CBSA) has released its 2023 CBSA Policy + Advocacy Report, which summarizes CBSA’s engagement during the Colorado legislative session, the regulatory process to implem...

Learn More

Weekly Policy Blog: PDAB Deems Trikafta “Not Unaffordable” in First Affordability Decision

On Friday, December 8, the Colorado Prescription Drug Affordability Board (PDAB or Board) completed its first affordability review and unanimously voted that the selected drug, a cystic fibrosis drug...

Learn More

Weekly Policy Blog: Congratulations to CBSA’s 2023 Legislators of the Year 

On November 15, 2023, CBSA held its 20th Annual Awards Celebration presented by AGC Biologics. This annual celebration highlights the spirit and drive of Colorado’s vibrant life sciences ecosystem, br...

Learn More